Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Depreciation & Amortization (CF) (2022 - 2025)

Historic Depreciation & Amortization (CF) for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to $22000.0.

  • PAVmed's Depreciation & Amortization (CF) changed N/A to $22000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $156000.0, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2024, which is 5914.05% down from last year.
  • Latest data reveals that PAVmed reported Depreciation & Amortization (CF) of $22000.0 as of Q3 2025.
  • Over the past 5 years, PAVmed's Depreciation & Amortization (CF) peaked at $815000.0 during Q2 2022, and registered a low of $22000.0 during Q2 2025.
  • In the last 4 years, PAVmed's Depreciation & Amortization (CF) had a median value of $643000.0 in 2022 and averaged $459714.3.
  • Per our database at Business Quant, PAVmed's Depreciation & Amortization (CF) soared by 23657.41% in 2023 and then plummeted by 9278.69% in 2025.
  • Over the past 4 years, PAVmed's Depreciation & Amortization (CF) (Quarter) stood at $726000.0 in 2022, then decreased by 0.14% to $725000.0 in 2023, then crashed by 90.48% to $69000.0 in 2024, then crashed by 68.12% to $22000.0 in 2025.
  • Its Depreciation & Amortization (CF) stands at $22000.0 for Q3 2025, versus $22000.0 for Q2 2025 and $43000.0 for Q1 2025.